Fig. 5From: ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatmentsEffects of everolimus and CDD866 on body weight. Non-tumor (a), CT-26 tumor (b), and body weight on day 14 (c). Values are expressed as means ± SEM (n = 8–10). Percent changes of body weight were calculated in comparison to treatment start. ** P < 0.01 versus non-tumor control; ++ P < 0.01 versus non-tumor everolimus; && P < 0.01 versus CT-26 control; ## P < 0.01 versus CT-26 everolimusBack to article page